Asieris Pharmaceuticals is a China-based biopharmaceutical company developing innovative therapies in genitourinary tumors and women's health. Its focus areas span urologic oncology (bladder cancer diagnosis and treatment), women's health, and breast and gynecologic oncology, with marquee assets Vesique (APL-1202) for bladder cancer and Cevira… - View it on GitHub